MedTrace Logo

Comparison Between Analog Neurocognitive Tests Conducted by a Trained Test Leader Versus Self-administered Digital Tests

NCT05253612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-06

No results posted yet for this study

Summary

The study has a randomized crossover design including qualitative interviews of the participant's test experiences. Healthy participants, ≥60 years are eligible to participate in the study. Cognitive function will be measured by using the International Study Group of Postoperative Cognitive Dysfunction (ISPOCD) test battery and the Mindmore digital test battery. The participants will self-report their likelihood of depression with the geriatric depression scale-15, their user experience of the digital test by a modified version of System Usability scale, and answer questionnaires targeting their experiences of the test sessions. Furthermore, concentration difficulties, according to the Swedish Quality of Recovery-scale will also be measured.

Conditions

  • Neurocognitive Decline
  • Feasibility
  • Costs
  • Interviews

Interventions

DIAGNOSTIC_TEST

Analog testing conducted by a trained test leader using, ISPOCD test battery

Cognitive function will be measured by using the International Study Group of Postoperative Cognitive Dysfunction (ISPOCD) analog test battery v

DIAGNOSTIC_TEST

self-administered Mindmore digital cognitive screening battery

Cognitive function will be measured by using the Mindmores digital test battery

Sponsors & Collaborators

Principal Investigators

  • Ulrica Nilsson, Professor · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-17
Primary Completion
2022-04-05
Completion
2022-04-05

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253612 on ClinicalTrials.gov